Regulatory News:

SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an innovative company that develops and markets disposable medical devices designed to make spine surgery safer, reported today that its consolidated full-year 2015 revenue grew by 43%, to €6.3 million.

Pierre Jérôme, CEO and co-founder of SpineGuard, said: “We closed 2015 with another terrific quarter. It particularly reflects the excellent sales momentum in the USA and the solid progression in France, the two markets where SpineGuard sells directly. With the recent first DSG™ ‘smart’ screw surgery and €7.7M financing, we are entering 2016 with high confidence, strong optimism and significant resources.”

€ thousands - IFRS     2015     2014     Variance
First Quarter     1,517     1,035     +47%
Second Quarter     1,452     1,075     +35%
Half-Year     2,970     2,110     +41%
Third Quarter     1 646     1 133     +45%
Fourth Quarter     1 730     1 193     +45%
Second Half     3 376     2 326     +45%
Full year     6 346     4 436     +43%

Unaudited

Global revenue in the fourth quarter of 2015 increased 45% to €1,730k, compared with €1,193k in the fourth quarter of 2014. In the USA, the growth was 64% and 44% at constant exchange rate (cc).

7,449 PediGuard units were sold in FY 2015 compared with 6,063 in FY 2014, including 4,306 in the United States, representing 58% of total units sold with a revenue increasing by 56% (31% cc) to €5,120k compared with €3,274k in FY 2014.

Previous press releases:

SpineGuard secures €7.7M debt financing with Bpifrance and IPF Partners, on January 11, 2016.

CE mark and world’s first spinal fusion surgery performed with single-step insertion of DSG™ Technology enabled screws, on January 5, 2016.

Next financial press release: 2015 annual results, on March 23, 2016.

SpineGuard will participate to the 'Invest Securities Biomed Event' on January 27 in Paris.

About SpineGuard®
Co-founded in 2009 in France and the USA by Pierre Jérôme and Stéphane Bette, SpineGuard’s mission is to make spine surgery safer. Its primary objective is to establish its proprietary DSG™ (Dynamic Surgical Guidance) technology as the global standard of surgical care, initially for safer screw placement in spine surgery and then in other surgeries. PediGuard®, the first device designed using DSG was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer. It is the world’s first and only handheld device capable of alerting surgeons to potential pedicular or vertebral breaches. Over 40,000 surgical procedures have been performed worldwide with PediGuard. Numerous studies published in peer-reviewed medical and scientific journals have demonstrated the multiple benefits that PediGuard delivers to patients, surgical staff and hospitals. In 2015, SpineGuard started to expand the applications of DSG into pedicle screws through partnerships with innovative surgical companies in France and the US. SpineGuard has offices in San Francisco and Paris. For further information, visit www.spineguard.com.

Disclaimer

The SpineGuard securities may not be offered or sold in the United States as they have not been and will not be registered under the Securities Act or any United States state securities laws, and SpineGuard does not intend to make a public offer of its securities in the United States. This is an announcement and not a prospectus, and the information contained herein does and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in the United States in which such offer, solicitation or sale would be unlawful prior to registration or exemption from registration.